Lv1
16 积分 2026-03-03 加入
Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia
1天前
待确认
Screening and Activity Evaluation of Novel BCR-ABL/T315I TyrosineKinase Inhibitors
2天前
已完结
Research Status, Synthesis and Clinical Application of RecentlyMarketed and Clinical BCR-ABL Inhibitors
2天前
已完结
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia
9天前
已完结
Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer
1个月前
已完结
皖公网安备34019202002308
